21PBaseline total metabolic tumor volume assessed by 18FDG-PET/CT predicts outcome in advanced melanoma patients treated with pembrolizumab. (17th December 2018) - Awada, G; Özdemir, I; Schwarze, J K; Daeninck, E; Gondry, O; Jansen, Y; Seremet, T; Keyaerts, M; Everaert, H; Neyns, B